{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:18:55Z","timestamp":1791314335916,"version":"4.3.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1007\/s10585-007-9112-8","type":"journal-article","created":{"date-parts":[[2007,11,15]],"date-time":"2007-11-15T05:27:55Z","timestamp":1195104475000},"page":"599-608","source":"Crossref","is-referenced-by-count":138,"title":["Bone metastasis: pathogenesis and therapeutic implications"],"prefix":"10.1007","volume":"24","author":[{"given":"Philippe","family":"Clezardin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Teti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,16]]},"reference":[{"key":"9112_CR1","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massague J (2006) Cancer metastasis: building a framework. Cell 127:679\u2013695","journal-title":"Cell"},{"key":"9112_CR2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/nm1469","volume":"12","author":"PS Steeg","year":"2006","unstructured":"Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12:895\u2013904","journal-title":"Nat Med"},{"key":"9112_CR3","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/S0140-6736(07)60781-8","volume":"369","author":"SA Eccles","year":"2007","unstructured":"Eccles SA, Welch DR (2007) Metastasis: recent discoveries and novel treatment strategies. Lancet 369:1742\u20131757","journal-title":"Lancet"},{"key":"9112_CR4","unstructured":"Hassan I (2006) Lung, metastases. In: Shoffer K, Coombs BD, Webb R, Krasny R, White CR, (eds) e-Medicine specialties\u2014radiology\u2014chest ( http:\/\/www.emedicine.com\/radio\/topic404.htm ). Cited October 25, 2006"},{"key":"9112_CR5","unstructured":"Khan AN, Macdonald S (2007) Liver, metastasis. In: Amin Z, Coombs BD, Schmiedl UP, Krasny, RM, Karani J (eds) e-Medicine specialties\u2014radiology\u2014liver ( http:\/\/www.emedicine.com\/radio\/topic394.htm ). Cited January 24, 2007"},{"key":"9112_CR6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/sj.bjc.6601198","volume":"89","author":"JJ James","year":"2003","unstructured":"James JJ, Evans AJ, Pinder SE et al (2003) Bone metastases from breast carcinoma: histopathological\u2013radiological correlations and prognostic features. Br J Cancer 89:660\u2013665","journal-title":"Br J Cancer"},{"key":"9112_CR7","unstructured":"Wilfred CG, Muttarak M (2007) Bone metastases. In: Abdel-Dayem HM, Coombs BD, Peh WCG, Krasny RM, Chew FS (eds) e-Medicine specialties\u2014radiology\u2014musculoskeletal ( http:\/\/www.emedicine.com\/radio\/topic88.htm ). Cited February 16, 2007"},{"key":"9112_CR8","unstructured":"Khosla A (2007) Brain, metastases. In: Creasy JL, Coombs BD, DeLaPaz RL, Krasny RM, Smirniotopoulos JG (eds) e-Medicine specialties\u2014radiology\u2014brain\/spine ( http:\/\/www.emedicine.com\/radio\/topic101.htm ). Cited January 24, 2007"},{"key":"9112_CR9","unstructured":"Wansaicheong G, Goh J (2205) Adrenal metastases. In: Krinsky G Coombs BD, Friedman AC, Krasny RM, Lin EC (eds) e-Medicine specialties\u2014radiology\u2014genitourinary ( http:\/\/www.emedicine.com\/radio\/topic17.htm ). Cited January 3, 2005"},{"key":"9112_CR10","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s\u20136249s","journal-title":"Clin Cancer Res"},{"key":"9112_CR11","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.1996.14.8.2197","volume":"14","author":"PA Greenberg","year":"1996","unstructured":"Greenberg PA, Hortobagyi GN, Smith TL et al (1996) Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 14:2197\u20132205","journal-title":"J Clin Oncol"},{"key":"9112_CR12","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0022-5347(17)51417-2","volume":"130","author":"K Fan","year":"1983","unstructured":"Fan K, Peng CF (1983) Predicting the probability of bone metastasis through histological grading of prostate carcinoma: a retrospective correlative analysis of 81 autopsy cases with antemortem transurethral resection specimen. J Urol 130:708\u2013711","journal-title":"J Urol"},{"key":"9112_CR13","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/bjc.1998.52","volume":"77","author":"RE Coleman","year":"1998","unstructured":"Coleman RE, Smith P, Rubens RD (1998) Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer 77:336\u2013340","journal-title":"Br J Cancer"},{"key":"9112_CR14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF01975000","volume":"21","author":"PG Koenders","year":"1992","unstructured":"Koenders PG, Beex LV, Kloppenborg PW et al (1992) Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat 21:173\u2013180","journal-title":"Breast Cancer Res Treat"},{"key":"9112_CR15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1006308619659","volume":"59","author":"EF Solomayer","year":"2000","unstructured":"Solomayer EF, Diel IJ, Meyberg GC et al (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59:271\u2013278","journal-title":"Breast Cancer Res Treat"},{"key":"9112_CR16","doi-asserted-by":"crossref","first-page":"6264s","DOI":"10.1158\/1078-0432.CCR-06-0654","volume":"12","author":"RJ Cook","year":"2006","unstructured":"Cook RJ, Major P (2006) Multistate analysis of skeletal events in patients with bone metastases. Clin Cancer Res 12:6264s\u20136269s","journal-title":"Clin Cancer Res"},{"key":"9112_CR17","doi-asserted-by":"crossref","unstructured":"Callaway MP, Briggs JC (1989) The incidence of late recurrence (greater than 10\u00a0years); an analysis of 536 consecutive cases of cutaneous melanoma. Br J Plast Surg 4246\u20134249","DOI":"10.1016\/S0007-1226(89)90111-2"},{"key":"9112_CR18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/ncponc0685","volume":"4","author":"MJ Slade","year":"2007","unstructured":"Slade MJ, Coombes RC (2007) The clinical significance of disseminated tumor cells in breast cancer. Nat Clin Pract Oncol 4:30\u201341","journal-title":"Nat Clin Pract Oncol"},{"key":"9112_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ncponc0688","volume":"4","author":"CR Dunstan","year":"2007","unstructured":"Dunstan CR, Felsenberg D, Seibel MJ (2007) Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol 4:42\u201355","journal-title":"Nat Clin Pract Oncol"},{"key":"9112_CR20","first-page":"410","volume":"100","author":"AD Khosa","year":"2007","unstructured":"Khosa AD, Nayyar MS, Beirne JC (2007) Osteochemonecrosis of jaws and bisphosphonates. Ir Med J 100:410\u2013411","journal-title":"Ir Med J"},{"key":"9112_CR21","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","volume":"350","author":"GD Roodman","year":"2004","unstructured":"Roodman GD (2004) Mechanism of bone metastases. N Eng J Med 350:1655\u20131664","journal-title":"N Eng J Med"},{"key":"9112_CR22","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","volume":"12","author":"TA Guise","year":"2006","unstructured":"Guise TA, Mohammad KS, Clines G et al (2006) Basic mechanisms responsible for osteolytic and osteoblastic bone metastases. Clin Cancer Res 12:6213s\u20136216s","journal-title":"Clin Cancer Res"},{"key":"9112_CR23","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar2169","volume":"9","author":"MS Virk","year":"2007","unstructured":"Virk MS, Lieberman JR (2007) Tumor metastasis to bone. Arthritis Res Ther 9:S5","journal-title":"Arthritis Res Ther"},{"key":"9112_CR24","first-page":"931","volume":"93","author":"AAN Rose","year":"2006","unstructured":"Rose AAN, Siegel PM (2006) Breast cancer-derived factors facilitate osteolytic bone metastasis. Bull Cancer 93:931\u2013943","journal-title":"Bull Cancer"},{"key":"9112_CR25","first-page":"103","volume":"20","author":"L Ye","year":"2007","unstructured":"Ye L, Kynaston HG, Jiang WG (2007) Bone metastasis in prostate cancer: molecular and cellular mechanisms. Int J Mol Med 20:103\u2013111","journal-title":"Int J Mol Med"},{"key":"9112_CR26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/jbmr.070109","volume":"22","author":"MA Karsdal","year":"2007","unstructured":"Karsdal MA, Martin TJ, Bollerslev J et al (2007) Are nonresorbing osteoclasts sources of bone anabolic activity? J Bone Miner Res 22:487\u2013494","journal-title":"J Bone Miner Res"},{"key":"9112_CR27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H et al (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50\u201356","journal-title":"Nature"},{"key":"9112_CR28","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1158\/0008-5472.CAN-03-3958","volume":"64","author":"Z Liang","year":"2004","unstructured":"Liang Z, Wu T, Lou H et al (2004) Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4. Cancer Res 64:4302\u20134308","journal-title":"Cancer Res"},{"key":"9112_CR29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1359\/JBMR.041109","volume":"20","author":"YX Sun","year":"2005","unstructured":"Sun YX, Schneider A, Jung Y et al (2005) Skeletal localization and neutralization of the SDF-1(CXCL12)\/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in\u00a0vivo. J Bone Miner Res 20:318\u2013329","journal-title":"J Bone Miner Res"},{"key":"9112_CR30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","volume":"440","author":"DH Jones","year":"2006","unstructured":"Jones DH, Nakashima T, Sanchez OH et al (2006) Regulation of cancer cell migration and bone metastasis by RANKL. Nature 440:692\u2013696","journal-title":"Nature"},{"key":"9112_CR31","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1158\/0008-5472.CAN-06-4499","volume":"67","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Bachelier R, Treilleux I et al (2007) Tumor \u03b1v\u03b23 integrin is a therapeutic target for breast cancer bone metastases. Cancer Res 67:5821\u20135830","journal-title":"Cancer Res"},{"key":"9112_CR32","doi-asserted-by":"crossref","first-page":"8648","DOI":"10.1158\/0008-5472.CAN-06-1544","volume":"66","author":"CL Hall","year":"2006","unstructured":"Hall CL, Dai J, van Golen KL et al (2006) Type I collagen receptor (\u03b12\u03b21) signaling promotes the growth of human prostate cancer cells within the bone. Cancer Res 66:8648\u20138654","journal-title":"Cancer Res"},{"key":"9112_CR33","doi-asserted-by":"crossref","unstructured":"Rucci N, \u0160u\u0161a M, Teti A (2007) Inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases. Anti-Cancer Agents in Med Chem (in press)","DOI":"10.2174\/187152008783961905"},{"key":"9112_CR34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/14728222.11.1.91","volume":"11","author":"J Homsi","year":"2007","unstructured":"Homsi J, Cubitt C, Daud A (2007) The Src signaling pathway: a potential target in melanoma and other malignancies. Expert Opin Ther Targets 11:91\u2013100","journal-title":"Expert Opin Ther Targets"},{"key":"9112_CR35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","volume":"64","author":"P Soriano","year":"1991","unstructured":"Soriano P, Montgomery C, Geske R et al (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693\u2013702","journal-title":"Cell"},{"issue":"Suppl 1","key":"9112_CR36","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1677\/erc.1.01297","volume":"13","author":"S Hiscox","year":"2006","unstructured":"Hiscox S, Morgan L, Green T et al (2006) Src as a therapeutic target in anti-hormone\/anti-growth factor-resistant breast cancer. Endocr Relat Cancer 13(Suppl 1):S53\u2013S59","journal-title":"Endocr Relat Cancer"},{"key":"9112_CR37","first-page":"5028","volume":"63","author":"A Myoui","year":"2003","unstructured":"Myoui A, Nishimura R, Williams PJ et al (2003) c-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. Cancer Res 63:5028\u20135033","journal-title":"Cancer Res"},{"key":"9112_CR38","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/jpet.106.102004","volume":"318","author":"N Rucci","year":"2006","unstructured":"Rucci N, Recchia I, Angelucci A et al (2006) Inhibition of protein kinase c-Src reduces the incidence of breast cancer metastases and increases survival in mice: implications for therapy. J Pharmacol Exp Ther 318:161\u2013172","journal-title":"J Pharmacol Exp Ther"},{"key":"9112_CR39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1331\/J520-X177-5587-6556","volume":"47","author":"DA Hussar","year":"2007","unstructured":"Hussar DA (2007) New drugs: paliperidone, dasatinib, and decitabine. J Am Pharm Assoc 47:298\u2013302","journal-title":"J Am Pharm Assoc"},{"key":"9112_CR40","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1046\/j.1523-1755.63.s85.2.x","volume":"85","author":"BF Boyce","year":"2003","unstructured":"Boyce BF, Xing L, Shakespeare W et al (2003) Regulation of bone remodeling and emerging breakthrough drugs for osteoporosis and osteolytic bone metastases. Kidney Int Suppl 85:S2\u2013S5","journal-title":"Kidney Int Suppl"},{"key":"9112_CR41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ijc.20223","volume":"111","author":"K Knerr","year":"2004","unstructured":"Knerr K, Ackermann K, Neidhart T et al (2004) Bone metastasis: osteoblasts affect growth and adhesion regulons in prostate tumor cells and provoke osteomimicry. Int J Cancer 111:152\u2013159","journal-title":"Int J Cancer"},{"key":"9112_CR42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3816\/CGC.2006.n.034","volume":"5","author":"LW Chung","year":"2006","unstructured":"Chung LW, Huang WC, Sung SY et al (2006) Stromal-epithelial interaction in prostate cancer progression. Clin Genitourin Cancer 5:162\u2013170","journal-title":"Clin Genitourin Cancer"},{"key":"9112_CR43","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/MCB.25.19.8581-8591.2005","volume":"25","author":"J Pratap","year":"2005","unstructured":"Pratap J, Javed A, Languino LR et al (2005) The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol 25:8581\u20138591","journal-title":"Mol Cell Biol"},{"key":"9112_CR44","first-page":"2631","volume":"63","author":"GL Barnes","year":"2003","unstructured":"Barnes GL, Javed A, Waller SM et al (2003) Osteoblast-related transcription factors Runx2 (Cbfa1\/AML3) and MSX2 mediate the expression of bone sialoprotein in human metastatic breast cancer cells. Cancer Res 63:2631\u20132637","journal-title":"Cancer Res"},{"key":"9112_CR45","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-4598-6-18","volume":"6","author":"B Desai","year":"2007","unstructured":"Desai B, Rogers MJ, Chellaiah MA (2007) Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells. Mol Cancer 6:18","journal-title":"Mol Cancer"},{"key":"9112_CR46","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1158\/0008-5472.CAN-04-3448","volume":"65","author":"WC Huang","year":"2005","unstructured":"Huang WC, Xie Z, Konaka H et al (2005) Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway. Cancer Res 65:2303\u20132313","journal-title":"Cancer Res"},{"key":"9112_CR47","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jcb.20644","volume":"97","author":"DA Campo McKnight","year":"2006","unstructured":"Campo McKnight DA, Sosnoski DM, Koblinski JE et al (2006) Roles of osteonectin in the migration of breast cancer cells into bone. J Cell Biochem 97:288\u2013302","journal-title":"J Cell Biochem"},{"key":"9112_CR48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.cgt.7700659","volume":"11","author":"H Adwan","year":"2004","unstructured":"Adwan H, B\u00e4uerle TJ, Berger MR (2004) Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells. Cancer Gene Ther 11:109","journal-title":"Cancer Gene Ther"},{"key":"9112_CR49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Kang Y, Serganova I et al (2005) Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115:44\u201355","journal-title":"J Clin Invest"},{"key":"9112_CR50","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1073\/pnas.0409121102","volume":"102","author":"A Javed","year":"2005","unstructured":"Javed A, Barnes GL, Pratap J et al (2005) Impaired intranuclear trafficking of Runx2 (AML3\/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in\u00a0vivo. Proc Natl Acad Sci USA 102:1454\u20131459","journal-title":"Proc Natl Acad Sci USA"},{"key":"9112_CR51","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-006-9279-8","volume":"101","author":"A Bellahc\u00e8ne","year":"2007","unstructured":"Bellahc\u00e8ne A, Bachelier R, Detry C et al (2007) Transcriptome analysis reveals an osteoblast-like phenotype for human osteotropic breast cancer cells. Breast Cancer Res Treat 101:135\u2013148","journal-title":"Breast Cancer Res Treat"},{"key":"9112_CR52","first-page":"5386","volume":"57","author":"AJ Littlewood-Evans","year":"1997","unstructured":"Littlewood-Evans AJ, Bilbe G, Bowler WB et al (1997) The osteoclast-associated protease cathepsin K is expressed in human breast carcinoma. Cancer Res 57:5386\u20135390","journal-title":"Cancer Res"},{"key":"9112_CR53","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1158\/0008-5472.CAN-06-3940","volume":"67","author":"C Le Gall","year":"2007","unstructured":"Le Gall C, Bellahc\u00e8ne A, Bonnelye E et al (2007) A cathepsin K inhibitor reduces breast cancer-induced osteolysis and skeletal tumor burden. Cancer Res 67:9894\u20139902","journal-title":"Cancer Res"},{"key":"9112_CR54","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/jcb.21214","volume":"101","author":"C Morrissey","year":"2007","unstructured":"Morrissey C, Vessella RL (2007) The role of tumor microenvironment in prostate cancer bone metastasis. J Cell Biochem 101:873\u2013886","journal-title":"J Cell Biochem"},{"key":"9112_CR55","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1172\/JCI27071","volume":"115","author":"LG Raisz","year":"2005","unstructured":"Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, prospects. J Clin Invest 115:3318\u20133325","journal-title":"J Clin Invest"},{"key":"9112_CR56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1196\/annals.1365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis DJ, Androulakis II (2006) Bone remodeling. Ann N Y Acad Sci 1092:385\u2013396","journal-title":"Ann N Y Acad Sci"},{"key":"9112_CR57","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","volume":"13","author":"M Zaidi","year":"2007","unstructured":"Zaidi M (2007) Skeletal remodeling in health and disease. Nature Med 13:791\u2013801","journal-title":"Nature Med"},{"key":"9112_CR58","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292\u2013304","journal-title":"Nat Rev Immunol"},{"key":"9112_CR59","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.2741\/2024","volume":"11","author":"S Varghese","year":"2006","unstructured":"Varghese S (2006) Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions. Front Biosci 11:2949\u20132966","journal-title":"Front Biosci"},{"key":"9112_CR60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1146\/annurev.immunol.25.022106.141631","volume":"25","author":"O Kollet","year":"2007","unstructured":"Kollet O, Dar A, Lapidot T (2007) The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization. Annu Rev Immunol 25:51\u201369","journal-title":"Annu Rev Immunol"},{"key":"9112_CR61","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.0105-2896.2005.00333.x","volume":"208","author":"HL Aguila","year":"2005","unstructured":"Aguila HL, Rowe DW (2005) Skeletal development, bone remodeling, and hematopoiesis. Immunol Rev 208:7\u201318","journal-title":"Immunol Rev"},{"key":"9112_CR62","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","volume":"1","author":"S Paget","year":"1889","unstructured":"Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:571\u2013573","journal-title":"Lancet"},{"key":"9112_CR63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ (2003) The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer 3:453\u2013458","journal-title":"Nat Rev Cancer"},{"key":"9112_CR64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2353\/ajpath.2007.051276","volume":"170","author":"R Schwaninger","year":"2007","unstructured":"Schwaninger R, Rentsch CA, Wetterwald A et al (2007) Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases. Am J Pathol 170:160\u2013175","journal-title":"Am J Pathol"},{"key":"9112_CR65","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/cncr.11129","volume":"97","author":"TA Guise","year":"2003","unstructured":"Guise TA, Yin JJ, Mohammad KS (2003) Role of endothelin-1 in osteoblastic bone metastases. Cancer 97:779\u2013784","journal-title":"Cancer"},{"key":"9112_CR66","doi-asserted-by":"crossref","first-page":"6296s","DOI":"10.1158\/1078-0432.CCR-06-0929","volume":"12","author":"MA Carducci","year":"2006","unstructured":"Carducci MA, Jimeno A (2006) Targeting bone metastasis in prostate cancer with endothelin receptor antagonists. Clin Cancer Res 12:6296s\u20136300s","journal-title":"Clin Cancer Res"},{"key":"9112_CR67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000101298","volume":"185","author":"CL Chaffer","year":"2007","unstructured":"Chaffer CL, Thompson EW, Williams ED (2007) Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 185:7\u201319","journal-title":"Cells Tissues Organs"},{"key":"9112_CR68","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1158\/0008-5472.CAN-05-3986","volume":"66","author":"L Li","year":"2006","unstructured":"Li L, Neaves WB (2006) Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66:4553\u20134557","journal-title":"Cancer Res"},{"key":"9112_CR69","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/bcr1021","volume":"7","author":"S Liu","year":"2005","unstructured":"Liu S, Dontu G, Wicha MS (2005) Mammary stem cells, self renewal pathways, and carcinogenesis. Breast Cancer Res 7:86\u201395","journal-title":"Breast Cancer Res"},{"key":"9112_CR70","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-05-3153","volume":"66","author":"MS Wicha","year":"2006","unstructured":"Wicha MS, Liu S, Dontu G (2006) Cancer stem cells: an old idea-a paradigm shift. Cancer Res 66:1883\u20131890","journal-title":"Cancer Res"},{"key":"9112_CR71","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.semcancer.2006.05.001","volume":"17","author":"SA Bapat","year":"2007","unstructured":"Bapat SA (2007) Evolution of cancer stem cells. Semin Cancer Biol 17:204\u2013213","journal-title":"Semin Cancer Biol"},{"key":"9112_CR72","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4161\/cc.5.16.3111","volume":"5","author":"DW Felsher","year":"2006","unstructured":"Felsher DW (2006) Tumor dormancy. Cell cycle 5:1808\u20131811","journal-title":"Cell cycle"},{"key":"9112_CR73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/jnci\/91.1.80","volume":"91","author":"TG Karrison","year":"1999","unstructured":"Karrison TG, Ferguson DJ, Meier P (1999) Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst 91:80\u201385","journal-title":"J Natl Cancer Inst"},{"key":"9112_CR74","first-page":"2541","volume":"60","author":"DM Cameron","year":"2000","unstructured":"Cameron DM, Schmidt EE, Kerkvliet N et al (2000) Temporal progression of metastasis in lung: cell survival, dormancy and location dependence of metastatic inefficiency. Cancer Res 60:2541\u20132546","journal-title":"Cancer Res"},{"key":"9112_CR75","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.4161\/cc.5.16.2995","volume":"5","author":"R Marches","year":"2006","unstructured":"Marches R, Scheuermann R, Uhr J (2006) Cancer dormancy. From mice to man. Cell Cycle 5:1772\u20131778","journal-title":"Cell Cycle"},{"key":"9112_CR76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1006\/scbi.2001.0382","volume":"11","author":"GN Naumov","year":"2001","unstructured":"Naumov GN, MacDonald IC, Chambers AF et al (2001) Solitary cancer cells as a possible source of tumour dormancy? Cancer Biol 11:271\u2013276","journal-title":"Cancer Biol"},{"key":"9112_CR77","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02040","volume":"425","author":"LM Calvi","year":"2003","unstructured":"Calvi LM, Adams GB, Weibrecht KW et al (2003) Osteoblastic cells regulate the hematopoietic stem cell niche. Nature 425:841\u2013846","journal-title":"Nature"},{"key":"9112_CR78","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1172\/JCI28568","volume":"116","author":"T Yin","year":"2006","unstructured":"Yin T, Li L (2006) The stem cell niche in bone. J Clin Invest 116:1195\u20131201","journal-title":"J Clin Invest"},{"key":"9112_CR79","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","volume":"4","author":"H Lu","year":"2006","unstructured":"Lu H, Ouyang W, Huang C (2006) Inflammation, a key event in cancer development. Mol Cancer Res 4:221\u2013233","journal-title":"Mol Cancer Res"},{"key":"9112_CR80","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1349-7006.2006.00197.x","volume":"97","author":"A Yoshimura","year":"2006","unstructured":"Yoshimura A (2006) Signal transduction of inflammation cytokines and tumor development. Cancer Sci 97:439\u2013447","journal-title":"Cancer Sci"},{"key":"9112_CR81","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1158\/0008-5472.CAN-05-2012","volume":"66","author":"T Hiraga","year":"2006","unstructured":"Hiraga T, Myoui A, Choi ME et al (2006) Stimulation of cyclooxygenase-2 expression by bone-dervided transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Res 66:2067\u20132073","journal-title":"Cancer Res"},{"key":"9112_CR82","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/138955707780859431","volume":"7","author":"FH Sarkar","year":"2007","unstructured":"Sarkar FH, Adsule S, Li Y, Padhye S (2007) Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. Mini Rev Med Chem 7:599\u2013608","journal-title":"Mini Rev Med Chem"},{"key":"9112_CR83","first-page":"4432","volume":"61","author":"S Morony","year":"2001","unstructured":"Morony S, Capparelli C, Sarosi I et al (2001) Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Res 61:4432\u20134436","journal-title":"Cancer Res"},{"key":"9112_CR84","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1158\/1078-0432.CCR-05-1933","volume":"12","author":"JJ Body","year":"2006","unstructured":"Body JJ, Facon T, Coleman RE et al (2006) A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer. Clin Cancer Res 12:1221\u20131228","journal-title":"Clin Cancer Res"},{"key":"9112_CR85","doi-asserted-by":"crossref","unstructured":"Lipton A, Steger GG, Figueroa J et al (2007) Randomized active-controlled phase II Study Of Denosumab Efficacy And Safety In Patients With Breast Cancer-Related Bone Metastases. J Clin Oncol Sep 4; [Epub ahead of print]","DOI":"10.1200\/JCO.2007.11.8604"},{"key":"9112_CR86","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/138955706778742759","volume":"6","author":"K Tsuchida","year":"2006","unstructured":"Tsuchida K, Sunada Y, Noji S et al (2006) Inhibitors of the TGF-beta superfamily and their clinical applications. Mini Rev Med Chem 6:1255\u20131261","journal-title":"Mini Rev Med Chem"},{"key":"9112_CR87","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1349-7006.2006.00357.x","volume":"98","author":"S Ehata","year":"2007","unstructured":"Ehata S, Hanyu A, Fujime M et al (2007) Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in\u00a0vitro invasion and in\u00a0vivo bone metastasis of a human breast cancer cell line. Cancer Sci 98:127\u2013133","journal-title":"Cancer Sci"},{"key":"9112_CR88","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00423-007-0150-0","volume":"392","author":"ME Eichhorn","year":"2007","unstructured":"Eichhorn ME, Kleespies A, Angele MK et al (2007) Angiogenesis in cancer: molecular mechanisms, clinical impact. Langenbecks Arch Surg 392:371\u2013379","journal-title":"Langenbecks Arch Surg"},{"key":"9112_CR89","doi-asserted-by":"crossref","first-page":"10921","DOI":"10.1158\/0008-5472.CAN-05-1809","volume":"65","author":"Y Kitagawa","year":"2005","unstructured":"Kitagawa Y, Dai J, Zhang J et al (2005) Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Cancer Res 65:10921\u201310929","journal-title":"Cancer Res"},{"key":"9112_CR90","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1158\/0008-5472.CAN-06-4238","volume":"67","author":"C Folkins","year":"2007","unstructured":"Folkins C, Man S, Xu P et al (2007) Anticancer therapies combining antiangiogenic and tumor cell cytotoxic effects reduce the tumor stem-like cell fraction in glioma xenograft tumors. Cancer Res 67:3560\u20133564","journal-title":"Cancer Res"},{"key":"9112_CR91","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11912-006-0045-1","volume":"8","author":"SG Thakkar","year":"2006","unstructured":"Thakkar SG, Choueiri TK, Garcia JA (2006) Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics. Curr Oncol Rep 8:108\u2013113","journal-title":"Curr Oncol Rep"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9112-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10585-007-9112-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-007-9112-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T14:32:53Z","timestamp":1559226773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10585-007-9112-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":91,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["9112"],"URL":"https:\/\/doi.org\/10.1007\/s10585-007-9112-8","relation":{},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}